Betamethasone Dipropionate Patent Expiration

Betamethasone Dipropionate is Used for treating plaque psoriasis. It was first introduced by Schering Corp Sub Schering Plough Corp in its drug Diprosone on Approved Prior to Jan 1, 1982. Other drugs containing Betamethasone Dipropionate are Alphatrex, Sernivo, Betamethasone Dipropionate, Diprolene, Diprolene Af. 25 different companies have introduced drugs containing Betamethasone Dipropionate.


Betamethasone Dipropionate Patents

Given below is the list of patents protecting Betamethasone Dipropionate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sernivo US10179137 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9364485 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9433630 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9439911 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9655907 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9775851 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms
Sernivo US9877974 Topical formulations comprising a steroid Aug 31, 2030 Primus Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Betamethasone Dipropionate's patents.

Given below is the list recent legal activities going on the following patents of Betamethasone Dipropionate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 06 Mar, 2024 US9433630
Payment of Maintenance Fee, 8th Yr, Small Entity 14 Dec, 2023 US9364485
Payment of Maintenance Fee, 4th Yr, Small Entity 15 Jul, 2022 US10179137
Payment of Maintenance Fee, 4th Yr, Small Entity 30 Jul, 2021 US9877974
Email Notification 26 Apr, 2021 US10179137
Change in Power of Attorney (May Include Associate POA) 26 Apr, 2021 US10179137
Correspondence Address Change 22 Apr, 2021 US10179137
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 22 Apr, 2021 US10179137
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 21 Apr, 2021 US9877974
Change in Power of Attorney (May Include Associate POA) 21 Apr, 2021 US9877974


Betamethasone Dipropionate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Betamethasone Dipropionate Generics

Several generic applications have been filed for Betamethasone Dipropionate. The first generic version for Betamethasone Dipropionate was by Actavis Mid Atlantic Llc and was approved on Jul 31, 1985. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Apr 10, 2024.

Given below is the list of companies who have filed for Betamethasone Dipropionate generic.


1. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment, augmented Prescription TOPICAL AB Aug 31, 1995


2. ALPHARMA US PHARMS

Alpharma Us Pharmaceuticals Division has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Alpharma Us Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE lotion Discontinued TOPICAL N/A Feb 3, 1987


3. ANDA REPOSITORY

Anda Repository Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE cream, augmented Discontinued TOPICAL N/A Jan 23, 2004


4. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment, augmented Prescription TOPICAL AB Apr 10, 2024


5. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE cream Prescription TOPICAL AB Oct 12, 2018


6. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE lotion, augmented Discontinued TOPICAL N/A Feb 13, 2018


7. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE lotion, augmented Prescription TOPICAL AB May 21, 2007


8. FOUGERA PHARMS INC

Fougera Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

(reference standard)

lotion Prescription TOPICAL AB Aug 12, 1985


9. GLENMARK PHARMS INC

Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

(reference standard)

cream, augmented Prescription TOPICAL AB Sep 23, 2008


10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE lotion, augmented Discontinued TOPICAL N/A Oct 11, 2019


11. LUPIN LTD

Lupin Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment, augmented Prescription TOPICAL AB Dec 18, 2019


12. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment Prescription TOPICAL AB Apr 12, 2022


13. PADAGIS US

Padagis Us Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment, augmented Discontinued TOPICAL N/A Nov 9, 2017


14. PERRIGO NEW YORK

Perrigo New York Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Perrigo New York.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE cream Discontinued TOPICAL N/A Nov 26, 1997


15. SAVAGE LABS

Savage Laboratories Inc Div Altana Inc has filed for 1 generic for Betamethasone Dipropionate. This eq 0.05% base version comes by the name ALPHATREX. Given below are the details of the strengths of this generic introduced by Savage Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE lotion Discontinued TOPICAL N/A Aug 12, 1985


16. SHREE HARI INTL

Shree Hari International Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Shree Hari Intl.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE lotion Discontinued TOPICAL N/A Aug 12, 1985


17. TARO

Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE

(reference standard)

lotion, augmented Prescription TOPICAL AB May 21, 2007
EQ 0.05% BASE/SPRAY spray Discontinued TOPICAL N/A Jun 17, 2020


18. TASMAN PHARMA

Tasman Pharma Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Tasman Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment Prescription TOPICAL AB Feb 18, 2022


19. TEVA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE cream Discontinued TOPICAL N/A Aug 10, 1987


20. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE ointment Prescription TOPICAL AB Jul 14, 2020


21. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.05% BASE cream Prescription TOPICAL AB Jan 11, 2019